Biblio
Export 924 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is F [Clear All Filters]
“The Potential Role of Selection Bias in the Association Between Coronary Atherosclerosis and Cognitive Impairment.”, J Alzheimers Dis, vol. 93, no. 4, pp. 1307-1316, 2023.
, “Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research.”, J Alzheimers Dis, vol. 95, no. 3, pp. 753-768, 2023.
, “Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.”, J Alzheimers Dis, vol. 92, no. 1, pp. 341-348, 2023.
, “Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.”, J Alzheimers Dis, vol. 96, no. 4, pp. 1767-1780, 2023.
, “Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.”, J Alzheimers Dis, vol. 95, no. 1, pp. 213-225, 2023.
, “Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”, J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
, “Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”, J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
, “Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort.”, J Alzheimers Dis, vol. 95, no. 1, pp. 93-117, 2023.
, “The Association Between Neuropathological Lesions and Body Mass Index Is Independent of Cognitive Abilities.”, J Alzheimers Dis, 2024.
, “Associations of Physical Activity Engagement with Cerebral Amyloid-β and Tau from Midlife.”, J Alzheimers Dis, vol. 100, no. 3, pp. 935-943, 2024.
, “Bisecting N-Acetylglucosamine Correlates with Phospho-Tau181 in Subjective Cognitive Decline but not in Control Cases.”, J Alzheimers Dis, 2024.
, “Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function.”, J Alzheimers Dis, vol. 97, no. 2, pp. 953-961, 2024.
, “Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: A pilot study.”, J Alzheimers Dis, p. 13872877241291253, 2024.
, “Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study.”, J Alzheimers Dis, 2024.
, “Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study.”, J Alzheimers Dis, 2024.
, “Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study.”, J Alzheimers Dis, 2024.
, “Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study.”, J Alzheimers Dis, 2024.
, “Mayo Normative Studies: Amyloid and Neurodegeneration Negative Normative Data for the Auditory Verbal Learning Test and Sex-Specific Sensitivity to Mild Cognitive Impairment/Dementia.”, J Alzheimers Dis, vol. 100, no. 3, pp. 879-897, 2024.
, “Mayo Normative Studies: Amyloid and Neurodegeneration Negative Normative Data for the Auditory Verbal Learning Test and Sex-Specific Sensitivity to Mild Cognitive Impairment/Dementia.”, J Alzheimers Dis, vol. 100, no. 3, pp. 879-897, 2024.
, “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
, “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
, “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
, “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
, “Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 2, pp. 623-637., 2024.
,